Mike Stadnisky

Mike Stadnisky is a seasoned professional in the life sciences sector with a diverse range of roles, including Volunteer Writer for Blood Origins since October 2024, focusing on wildlife conservation science. Currently serving as Chairman at Parhelia Biosciences and Managing Director at Thielsen Capital since 2022, Stadnisky is instrumental in driving innovation and funding in life sciences. Additional experience includes consulting as Principal at Foundry Scientific and advisory roles at Tercen and Recs. Formerly, Stadnisky held leadership positions at Phitonex and BD, achieving significant advancements in the fields of cytometry and informatics. Educational qualifications include a PhD in Microbiology and Immunology from the University of Virginia and a BS in Biochemistry from Clemson University.